Bronchopulmonary Dysplasia Treatment Market

The Bronchopulmonary Dysplasia Treatment Market is projected to reach USD 434.1 million in 2025 and USD 788.2 million by 2035, growing at a CAGR of 6.1%. On the basis of Drug Type, Bronchodilators are expected to lead the segment with 22.3% revenue share. On the basis of Therapy Type, Supplemental Oxygen will remain the dominant segment, accounting for a 32.6% market share.